The tumor suppressor PTEN has been well described as significantly mutated in other malignancies (Lawrence et al., 2014); the increased number of sequenced samples in our study allowed PTEN to be identified as such in CRC as well. The gene discussed is PTEN; the disease is colorectal carcinoma.